| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 54 | 2023 | 8626 | 3.710 |
Why?
|
| Blood Pressure | 42 | 2023 | 8533 | 2.860 |
Why?
|
| Ventricular Dysfunction, Left | 28 | 2023 | 2136 | 2.840 |
Why?
|
| Cardiovascular Diseases | 61 | 2023 | 15648 | 2.560 |
Why?
|
| Sex Characteristics | 10 | 2023 | 2643 | 2.430 |
Why?
|
| Heart Failure | 61 | 2023 | 11840 | 2.250 |
Why?
|
| Echocardiography | 42 | 2023 | 5044 | 2.180 |
Why?
|
| Ventricular Function, Left | 35 | 2024 | 3930 | 2.090 |
Why?
|
| Ventricular Remodeling | 24 | 2023 | 1273 | 1.980 |
Why?
|
| Hypertrophy, Left Ventricular | 13 | 2022 | 855 | 1.590 |
Why?
|
| Metabolome | 11 | 2017 | 1005 | 1.490 |
Why?
|
| Takotsubo Cardiomyopathy | 2 | 2022 | 127 | 1.350 |
Why?
|
| Atherosclerosis | 26 | 2021 | 3425 | 1.270 |
Why?
|
| Heart Ventricles | 14 | 2022 | 3831 | 1.130 |
Why?
|
| Coronary Vessels | 7 | 2022 | 3097 | 1.120 |
Why?
|
| Eicosanoids | 5 | 2023 | 284 | 1.100 |
Why?
|
| Echocardiography, Doppler | 12 | 2020 | 899 | 1.060 |
Why?
|
| Myocardium | 15 | 2023 | 4763 | 1.060 |
Why?
|
| Risk Factors | 112 | 2024 | 74831 | 1.010 |
Why?
|
| Brachial Artery | 6 | 2017 | 375 | 0.990 |
Why?
|
| Diabetes Mellitus | 19 | 2023 | 5891 | 0.980 |
Why?
|
| Middle Aged | 183 | 2024 | 222903 | 0.960 |
Why?
|
| Humans | 323 | 2024 | 765734 | 0.960 |
Why?
|
| Carotid Arteries | 7 | 2021 | 929 | 0.960 |
Why?
|
| Female | 231 | 2024 | 395961 | 0.960 |
Why?
|
| Heart Diseases | 9 | 2021 | 2820 | 0.960 |
Why?
|
| Male | 223 | 2023 | 363585 | 0.950 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2023 | 541 | 0.930 |
Why?
|
| Aging | 8 | 2022 | 8730 | 0.920 |
Why?
|
| Myocarditis | 2 | 2022 | 802 | 0.920 |
Why?
|
| Cardiomyopathies | 7 | 2023 | 2067 | 0.900 |
Why?
|
| Stroke Volume | 33 | 2024 | 5596 | 0.900 |
Why?
|
| Myocardial Contraction | 6 | 2015 | 1516 | 0.880 |
Why?
|
| Fetal Macrosomia | 1 | 2024 | 138 | 0.870 |
Why?
|
| Carbon Monoxide | 4 | 2020 | 560 | 0.860 |
Why?
|
| Aged | 144 | 2024 | 171050 | 0.840 |
Why?
|
| Longitudinal Studies | 36 | 2022 | 14745 | 0.840 |
Why?
|
| Prehypertension | 3 | 2017 | 63 | 0.780 |
Why?
|
| Hypercholesterolemia | 3 | 2018 | 1149 | 0.780 |
Why?
|
| Sex | 1 | 2022 | 53 | 0.780 |
Why?
|
| Hemodynamics | 9 | 2021 | 4184 | 0.750 |
Why?
|
| Obesity | 19 | 2023 | 13079 | 0.750 |
Why?
|
| Health Status Disparities | 3 | 2018 | 1880 | 0.730 |
Why?
|
| Heart | 10 | 2023 | 4417 | 0.720 |
Why?
|
| Vital Signs | 1 | 2022 | 147 | 0.720 |
Why?
|
| Electrocardiography | 11 | 2022 | 6401 | 0.700 |
Why?
|
| Antibodies, Viral | 9 | 2023 | 3211 | 0.690 |
Why?
|
| Systole | 11 | 2023 | 935 | 0.690 |
Why?
|
| Seroepidemiologic Studies | 2 | 2021 | 404 | 0.690 |
Why?
|
| Diastole | 12 | 2020 | 785 | 0.680 |
Why?
|
| Natriuretic Peptide, Brain | 15 | 2020 | 1736 | 0.680 |
Why?
|
| Adult Children | 1 | 2020 | 104 | 0.670 |
Why?
|
| Metabolomics | 8 | 2019 | 1668 | 0.670 |
Why?
|
| Antibody Formation | 3 | 2023 | 1391 | 0.660 |
Why?
|
| Pulmonary Edema | 3 | 2020 | 412 | 0.650 |
Why?
|
| Coronary Circulation | 5 | 2020 | 1602 | 0.640 |
Why?
|
| Sex Factors | 21 | 2022 | 10605 | 0.630 |
Why?
|
| Microcirculation | 2 | 2020 | 1280 | 0.620 |
Why?
|
| Adult | 96 | 2024 | 222974 | 0.610 |
Why?
|
| Adipokines | 2 | 2018 | 308 | 0.600 |
Why?
|
| Coronary Disease | 7 | 2019 | 5911 | 0.600 |
Why?
|
| Antihypertensive Agents | 9 | 2023 | 2033 | 0.590 |
Why?
|
| Electronic Health Records | 5 | 2024 | 4862 | 0.580 |
Why?
|
| Prognosis | 46 | 2023 | 29899 | 0.580 |
Why?
|
| Los Angeles | 4 | 2022 | 244 | 0.580 |
Why?
|
| Aged, 80 and over | 53 | 2024 | 59459 | 0.580 |
Why?
|
| Stroke | 12 | 2023 | 9747 | 0.570 |
Why?
|
| Hypertension, Pulmonary | 3 | 2023 | 1603 | 0.560 |
Why?
|
| Vascular Diseases | 3 | 2022 | 1159 | 0.550 |
Why?
|
| Coronary Artery Disease | 13 | 2022 | 6545 | 0.550 |
Why?
|
| Myocardial Infarction | 14 | 2023 | 11504 | 0.540 |
Why?
|
| American Heart Association | 5 | 2022 | 1047 | 0.540 |
Why?
|
| Atrial Function, Left | 4 | 2019 | 189 | 0.520 |
Why?
|
| Pacemaker, Artificial | 3 | 2011 | 827 | 0.520 |
Why?
|
| Natriuretic Peptides | 3 | 2011 | 153 | 0.510 |
Why?
|
| Risk Assessment | 36 | 2022 | 24279 | 0.510 |
Why?
|
| Cohort Studies | 37 | 2024 | 41631 | 0.510 |
Why?
|
| Vaccination | 12 | 2023 | 3427 | 0.510 |
Why?
|
| Multivariate Analysis | 19 | 2021 | 12056 | 0.500 |
Why?
|
| Longevity | 3 | 2016 | 1087 | 0.500 |
Why?
|
| Isocitrates | 1 | 2015 | 23 | 0.490 |
Why?
|
| Taurocholic Acid | 1 | 2015 | 43 | 0.490 |
Why?
|
| Incidence | 26 | 2021 | 21478 | 0.480 |
Why?
|
| Massachusetts | 18 | 2019 | 8876 | 0.480 |
Why?
|
| Diabetes Complications | 3 | 2020 | 1316 | 0.470 |
Why?
|
| Age Factors | 18 | 2021 | 18375 | 0.470 |
Why?
|
| Predictive Value of Tests | 28 | 2022 | 15390 | 0.470 |
Why?
|
| Age of Onset | 7 | 2021 | 3339 | 0.470 |
Why?
|
| Diabetes, Gestational | 1 | 2024 | 1263 | 0.470 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2015 | 165 | 0.460 |
Why?
|
| Health Personnel | 5 | 2022 | 3390 | 0.450 |
Why?
|
| Smoking | 8 | 2022 | 9077 | 0.450 |
Why?
|
| Proportional Hazards Models | 18 | 2022 | 12509 | 0.440 |
Why?
|
| Vaccines | 1 | 2022 | 841 | 0.440 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2013 | 68 | 0.430 |
Why?
|
| Myocardial Ischemia | 6 | 2022 | 2129 | 0.430 |
Why?
|
| Algorithms | 7 | 2024 | 14061 | 0.420 |
Why?
|
| Hospitalization | 6 | 2022 | 10806 | 0.420 |
Why?
|
| Peptide Fragments | 10 | 2020 | 5125 | 0.420 |
Why?
|
| Inflammatory Bowel Diseases | 6 | 2023 | 2429 | 0.420 |
Why?
|
| United States | 49 | 2023 | 72898 | 0.410 |
Why?
|
| Brain Ischemia | 3 | 2023 | 3000 | 0.410 |
Why?
|
| Cardiomyopathy, Hypertrophic | 4 | 2022 | 1339 | 0.400 |
Why?
|
| Cardiovascular System | 3 | 2016 | 840 | 0.400 |
Why?
|
| Family Health | 1 | 2017 | 1253 | 0.390 |
Why?
|
| Artificial Intelligence | 4 | 2023 | 2657 | 0.390 |
Why?
|
| Leisure Activities | 2 | 2016 | 310 | 0.390 |
Why?
|
| Phenotype | 14 | 2024 | 16706 | 0.380 |
Why?
|
| Exhalation | 2 | 2020 | 184 | 0.370 |
Why?
|
| Adiposity | 5 | 2020 | 1891 | 0.360 |
Why?
|
| Prospective Studies | 46 | 2023 | 54795 | 0.350 |
Why?
|
| Pericytes | 1 | 2013 | 299 | 0.350 |
Why?
|
| Heart Atria | 6 | 2022 | 1363 | 0.340 |
Why?
|
| Pyrroles | 2 | 2013 | 1119 | 0.330 |
Why?
|
| Ultrasonography | 10 | 2020 | 5986 | 0.330 |
Why?
|
| Amino Acids, Branched-Chain | 4 | 2020 | 266 | 0.330 |
Why?
|
| Critical Care | 3 | 2023 | 2712 | 0.320 |
Why?
|
| Growth Differentiation Factor 15 | 5 | 2014 | 198 | 0.320 |
Why?
|
| Indoles | 3 | 2024 | 1832 | 0.320 |
Why?
|
| Body Mass Index | 16 | 2024 | 13044 | 0.320 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2021 | 8926 | 0.320 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2021 | 3359 | 0.320 |
Why?
|
| Heart Block | 1 | 2011 | 391 | 0.320 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 1238 | 0.310 |
Why?
|
| Microvessels | 1 | 2013 | 589 | 0.310 |
Why?
|
| Workflow | 4 | 2023 | 861 | 0.310 |
Why?
|
| Ovarian Neoplasms | 5 | 2024 | 4900 | 0.310 |
Why?
|
| Atrial Fibrillation | 9 | 2022 | 5188 | 0.310 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2016 | 798 | 0.310 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2009 | 57 | 0.300 |
Why?
|
| Bundle-Branch Block | 1 | 2010 | 280 | 0.300 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2013 | 398 | 0.300 |
Why?
|
| Receptors, Cell Surface | 7 | 2014 | 2817 | 0.300 |
Why?
|
| Prevalence | 19 | 2019 | 15833 | 0.300 |
Why?
|
| Linear Models | 10 | 2021 | 5876 | 0.300 |
Why?
|
| Lipids | 6 | 2022 | 3315 | 0.300 |
Why?
|
| Research Design | 3 | 2022 | 6207 | 0.300 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 370 | 0.300 |
Why?
|
| Outpatients | 2 | 2018 | 1594 | 0.300 |
Why?
|
| Case-Control Studies | 11 | 2022 | 22224 | 0.290 |
Why?
|
| Troponin T | 3 | 2019 | 785 | 0.290 |
Why?
|
| Abdominal Fat | 1 | 2009 | 217 | 0.290 |
Why?
|
| Pulsatile Flow | 5 | 2016 | 318 | 0.290 |
Why?
|
| Aorta, Abdominal | 1 | 2010 | 596 | 0.290 |
Why?
|
| Atrioventricular Block | 1 | 2009 | 141 | 0.280 |
Why?
|
| Blood Glucose | 8 | 2021 | 6427 | 0.280 |
Why?
|
| Albuminuria | 4 | 2020 | 660 | 0.280 |
Why?
|
| Polymorphism, Single Nucleotide | 13 | 2022 | 16041 | 0.280 |
Why?
|
| Vitamin D Deficiency | 3 | 2014 | 1349 | 0.280 |
Why?
|
| Bone Marrow Cells | 2 | 2011 | 2412 | 0.280 |
Why?
|
| Health Surveys | 1 | 2017 | 4057 | 0.270 |
Why?
|
| Immunoglobulin G | 7 | 2023 | 4527 | 0.270 |
Why?
|
| Retrospective Studies | 26 | 2024 | 81457 | 0.270 |
Why?
|
| Insulin Resistance | 9 | 2021 | 3989 | 0.270 |
Why?
|
| Calcinosis | 2 | 2018 | 1477 | 0.270 |
Why?
|
| Genome-Wide Association Study | 12 | 2024 | 12800 | 0.270 |
Why?
|
| Time Factors | 23 | 2021 | 40066 | 0.260 |
Why?
|
| Enoxaparin | 1 | 2009 | 390 | 0.260 |
Why?
|
| Prosthesis Implantation | 1 | 2011 | 595 | 0.260 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2010 | 881 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2022 | 12238 | 0.260 |
Why?
|
| Cross-Sectional Studies | 21 | 2021 | 26284 | 0.260 |
Why?
|
| Cholesterol | 4 | 2021 | 2898 | 0.260 |
Why?
|
| Coronary Thrombosis | 1 | 2009 | 440 | 0.260 |
Why?
|
| Peripheral Arterial Disease | 2 | 2022 | 1311 | 0.260 |
Why?
|
| Manometry | 4 | 2019 | 457 | 0.250 |
Why?
|
| Movement | 1 | 2013 | 1461 | 0.250 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3101 | 0.250 |
Why?
|
| Taiwan | 2 | 2024 | 521 | 0.250 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3224 | 0.250 |
Why?
|
| Health Services Accessibility | 2 | 2022 | 5506 | 0.250 |
Why?
|
| Troponin I | 6 | 2020 | 655 | 0.250 |
Why?
|
| Isoxazoles | 2 | 2024 | 233 | 0.240 |
Why?
|
| Chromatography, Liquid | 3 | 2019 | 990 | 0.240 |
Why?
|
| Blood Pressure Determination | 2 | 2020 | 647 | 0.240 |
Why?
|
| Follow-Up Studies | 24 | 2020 | 39180 | 0.240 |
Why?
|
| Asymptomatic Diseases | 3 | 2018 | 583 | 0.240 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2022 | 2309 | 0.230 |
Why?
|
| Ventricular Function | 2 | 2021 | 403 | 0.230 |
Why?
|
| Blood | 2 | 2022 | 597 | 0.230 |
Why?
|
| Genetic Loci | 4 | 2019 | 2631 | 0.230 |
Why?
|
| Disease Progression | 9 | 2023 | 13614 | 0.230 |
Why?
|
| Prediabetic State | 3 | 2015 | 547 | 0.230 |
Why?
|
| Long QT Syndrome | 2 | 2020 | 474 | 0.230 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 1377 | 0.230 |
Why?
|
| Dihydrotestosterone | 2 | 2023 | 193 | 0.230 |
Why?
|
| Young Adult | 16 | 2021 | 59852 | 0.230 |
Why?
|
| Phthalazines | 2 | 2024 | 397 | 0.230 |
Why?
|
| Reproducibility of Results | 13 | 2023 | 20120 | 0.220 |
Why?
|
| Diagnostic Imaging | 2 | 2017 | 3526 | 0.220 |
Why?
|
| Lung | 4 | 2020 | 10031 | 0.220 |
Why?
|
| Mass Spectrometry | 4 | 2023 | 2194 | 0.220 |
Why?
|
| Heart Rate | 6 | 2020 | 4202 | 0.220 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2023 | 1094 | 0.210 |
Why?
|
| Ankle Brachial Index | 4 | 2022 | 166 | 0.210 |
Why?
|
| Dementia | 2 | 2022 | 2745 | 0.210 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2013 | 2046 | 0.210 |
Why?
|
| Cardiomegaly | 2 | 2018 | 589 | 0.210 |
Why?
|
| Odds Ratio | 7 | 2022 | 9647 | 0.210 |
Why?
|
| Adipose Tissue | 2 | 2018 | 3313 | 0.210 |
Why?
|
| Pandemics | 9 | 2023 | 8703 | 0.200 |
Why?
|
| Motor Activity | 1 | 2012 | 2705 | 0.200 |
Why?
|
| Genetic Variation | 5 | 2023 | 6607 | 0.200 |
Why?
|
| Immunization, Secondary | 2 | 2022 | 373 | 0.200 |
Why?
|
| Oxylipins | 2 | 2020 | 55 | 0.200 |
Why?
|
| Heart Function Tests | 1 | 2023 | 317 | 0.200 |
Why?
|
| Vaccines, Synthetic | 2 | 2022 | 621 | 0.190 |
Why?
|
| Proteomics | 4 | 2023 | 3910 | 0.190 |
Why?
|
| Retinal Vein | 1 | 2021 | 46 | 0.190 |
Why?
|
| Barbering | 1 | 2021 | 12 | 0.190 |
Why?
|
| Triglycerides | 6 | 2021 | 2441 | 0.190 |
Why?
|
| Heparin | 1 | 2009 | 1630 | 0.190 |
Why?
|
| Exercise | 7 | 2022 | 5937 | 0.190 |
Why?
|
| Radiopharmaceuticals | 5 | 2022 | 2699 | 0.180 |
Why?
|
| Awareness | 1 | 2005 | 653 | 0.180 |
Why?
|
| Community Pharmacy Services | 1 | 2021 | 52 | 0.180 |
Why?
|
| Cause of Death | 4 | 2017 | 3709 | 0.180 |
Why?
|
| Aortic Diseases | 2 | 2020 | 729 | 0.180 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2021 | 93 | 0.180 |
Why?
|
| Pyrazines | 2 | 2024 | 1204 | 0.180 |
Why?
|
| Stem Cells | 2 | 2011 | 3539 | 0.180 |
Why?
|
| C-Reactive Protein | 8 | 2022 | 3850 | 0.180 |
Why?
|
| Severity of Illness Index | 9 | 2021 | 15883 | 0.180 |
Why?
|
| Fluorine Radioisotopes | 2 | 2021 | 397 | 0.180 |
Why?
|
| Heart-Assist Devices | 2 | 2022 | 1296 | 0.180 |
Why?
|
| Deoxycytidine | 2 | 2024 | 889 | 0.180 |
Why?
|
| Carotid Artery Diseases | 3 | 2018 | 869 | 0.180 |
Why?
|
| Immunity, Humoral | 2 | 2022 | 605 | 0.180 |
Why?
|
| Neoplasms | 6 | 2021 | 22345 | 0.170 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2022 | 239 | 0.170 |
Why?
|
| Blood Flow Velocity | 4 | 2020 | 1381 | 0.170 |
Why?
|
| Patient Compliance | 2 | 2021 | 2692 | 0.170 |
Why?
|
| Immunoglobulin M | 2 | 2023 | 1528 | 0.160 |
Why?
|
| Telemedicine | 3 | 2021 | 3105 | 0.160 |
Why?
|
| Vitamin D | 2 | 2011 | 3272 | 0.160 |
Why?
|
| Stress, Mechanical | 2 | 2015 | 1669 | 0.160 |
Why?
|
| Glucose Tolerance Test | 3 | 2018 | 1180 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2019 | 1193 | 0.160 |
Why?
|
| Vasodilation | 2 | 2015 | 970 | 0.160 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2022 | 418 | 0.160 |
Why?
|
| Lactobacillus | 1 | 2020 | 213 | 0.160 |
Why?
|
| Ethylene Glycols | 1 | 2020 | 196 | 0.160 |
Why?
|
| Azithromycin | 1 | 2020 | 201 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2021 | 18061 | 0.160 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2017 | 353 | 0.150 |
Why?
|
| Scleroderma, Systemic | 1 | 2022 | 345 | 0.150 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2018 | 108 | 0.150 |
Why?
|
| Medical History Taking | 1 | 2022 | 778 | 0.150 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2021 | 263 | 0.150 |
Why?
|
| Risk Reduction Behavior | 3 | 2020 | 1123 | 0.150 |
Why?
|
| Atrial Function, Right | 1 | 2018 | 32 | 0.150 |
Why?
|
| Preventive Health Services | 2 | 2021 | 570 | 0.150 |
Why?
|
| Receptors, Androgen | 2 | 2023 | 1087 | 0.150 |
Why?
|
| Sphingolipids | 1 | 2020 | 177 | 0.150 |
Why?
|
| Parents | 3 | 2017 | 3592 | 0.150 |
Why?
|
| Ceramides | 1 | 2019 | 201 | 0.150 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2020 | 150 | 0.150 |
Why?
|
| Dyslipidemias | 3 | 2016 | 869 | 0.150 |
Why?
|
| Diphtheria Antitoxin | 1 | 2017 | 7 | 0.150 |
Why?
|
| BCG Vaccine | 1 | 2021 | 380 | 0.150 |
Why?
|
| Biological Factors | 1 | 2019 | 155 | 0.140 |
Why?
|
| Inhalation Exposure | 1 | 2020 | 432 | 0.140 |
Why?
|
| Quinazolines | 1 | 2024 | 1365 | 0.140 |
Why?
|
| Diphtheria | 1 | 2017 | 32 | 0.140 |
Why?
|
| Aorta | 3 | 2014 | 2027 | 0.140 |
Why?
|
| Renal Insufficiency | 1 | 2023 | 804 | 0.140 |
Why?
|
| Tibial Arteries | 1 | 2017 | 60 | 0.140 |
Why?
|
| Intestinal Absorption | 1 | 2018 | 399 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 833 | 0.140 |
Why?
|
| Cardiac Volume | 1 | 2018 | 196 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2021 | 561 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2024 | 11865 | 0.140 |
Why?
|
| Heart Transplantation | 2 | 2022 | 3310 | 0.140 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 429 | 0.140 |
Why?
|
| Neprilysin | 1 | 2020 | 484 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 1 | 2021 | 1077 | 0.140 |
Why?
|
| Antigens, Viral | 1 | 2021 | 995 | 0.140 |
Why?
|
| Forecasting | 2 | 2017 | 2936 | 0.140 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2022 | 532 | 0.130 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 284 | 0.130 |
Why?
|
| Sodium, Dietary | 1 | 2020 | 426 | 0.130 |
Why?
|
| Mouth Neoplasms | 1 | 2022 | 594 | 0.130 |
Why?
|
| Patient Care Planning | 2 | 2020 | 906 | 0.130 |
Why?
|
| Cardiology | 2 | 2021 | 1702 | 0.130 |
Why?
|
| Food | 1 | 2021 | 764 | 0.130 |
Why?
|
| Amyloid | 1 | 2021 | 853 | 0.130 |
Why?
|
| Plasma | 2 | 2017 | 579 | 0.130 |
Why?
|
| Breath Tests | 2 | 2015 | 297 | 0.130 |
Why?
|
| Protease Inhibitors | 1 | 2020 | 746 | 0.130 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2017 | 340 | 0.130 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 863 | 0.130 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 430 | 0.130 |
Why?
|
| Seasons | 1 | 2022 | 1522 | 0.130 |
Why?
|
| Carcinoma, Lobular | 1 | 2020 | 470 | 0.130 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 413 | 0.130 |
Why?
|
| Gastrointestinal Tract | 1 | 2022 | 834 | 0.130 |
Why?
|
| Health Status | 5 | 2020 | 4081 | 0.120 |
Why?
|
| Diabetic Angiopathies | 1 | 2020 | 805 | 0.120 |
Why?
|
| Family Characteristics | 1 | 2020 | 1001 | 0.120 |
Why?
|
| Anticoagulants | 2 | 2022 | 4862 | 0.120 |
Why?
|
| Choice Behavior | 1 | 2021 | 846 | 0.120 |
Why?
|
| Waist Circumference | 3 | 2016 | 934 | 0.120 |
Why?
|
| Automation | 1 | 2017 | 585 | 0.120 |
Why?
|
| Waiting Lists | 1 | 2020 | 777 | 0.120 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2022 | 2024 | 0.120 |
Why?
|
| Cholesterol, HDL | 4 | 2020 | 1811 | 0.120 |
Why?
|
| Anus Neoplasms | 2 | 2009 | 336 | 0.120 |
Why?
|
| Low Back Pain | 2 | 2013 | 987 | 0.120 |
Why?
|
| Hyperemia | 1 | 2016 | 224 | 0.120 |
Why?
|
| Aniline Compounds | 1 | 2020 | 1075 | 0.120 |
Why?
|
| Memory Disorders | 1 | 2021 | 1193 | 0.110 |
Why?
|
| DNA Replication | 1 | 2021 | 1432 | 0.110 |
Why?
|
| Logistic Models | 6 | 2021 | 13261 | 0.110 |
Why?
|
| Amyloidosis | 1 | 2022 | 885 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2020 | 20667 | 0.110 |
Why?
|
| Ischemic Attack, Transient | 2 | 2019 | 870 | 0.110 |
Why?
|
| Geriatric Assessment | 3 | 2018 | 1429 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2024 | 5693 | 0.110 |
Why?
|
| Breast Neoplasms | 6 | 2023 | 21053 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 1061 | 0.110 |
Why?
|
| Tetrazoles | 1 | 2020 | 920 | 0.110 |
Why?
|
| Galectin 3 | 1 | 2016 | 237 | 0.110 |
Why?
|
| Mutation | 3 | 2021 | 30184 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2022 | 1240 | 0.110 |
Why?
|
| Heart Massage | 1 | 2013 | 32 | 0.110 |
Why?
|
| Diet, Mediterranean | 1 | 2020 | 746 | 0.110 |
Why?
|
| Kidney Function Tests | 4 | 2013 | 683 | 0.110 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2017 | 611 | 0.110 |
Why?
|
| 2-Aminoadipic Acid | 1 | 2013 | 32 | 0.110 |
Why?
|
| Doxorubicin | 1 | 2020 | 2229 | 0.110 |
Why?
|
| Piperazines | 1 | 2024 | 2546 | 0.110 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 895 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2022 | 1303 | 0.110 |
Why?
|
| Pilot Projects | 4 | 2021 | 8732 | 0.110 |
Why?
|
| Carbonated Beverages | 1 | 2014 | 209 | 0.110 |
Why?
|
| Vascular Resistance | 1 | 2016 | 941 | 0.110 |
Why?
|
| Observer Variation | 3 | 2015 | 2611 | 0.110 |
Why?
|
| Animals | 16 | 2021 | 168731 | 0.110 |
Why?
|
| Ambulatory Care | 2 | 2021 | 2778 | 0.100 |
Why?
|
| Pre-Eclampsia | 1 | 2022 | 1261 | 0.100 |
Why?
|
| Carcinoma in Situ | 2 | 2009 | 776 | 0.100 |
Why?
|
| Arteries | 2 | 2015 | 1118 | 0.100 |
Why?
|
| Heme | 1 | 2015 | 316 | 0.100 |
Why?
|
| Cerebral Infarction | 2 | 2015 | 970 | 0.100 |
Why?
|
| Antigens, CD34 | 2 | 2013 | 656 | 0.100 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2020 | 1082 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 2 | 2018 | 2023 | 0.100 |
Why?
|
| Biological Specimen Banks | 1 | 2018 | 787 | 0.100 |
Why?
|
| Bayes Theorem | 1 | 2021 | 2354 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2015 | 23589 | 0.100 |
Why?
|
| Elastic Modulus | 1 | 2013 | 208 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 22321 | 0.100 |
Why?
|
| Comorbidity | 4 | 2020 | 10567 | 0.100 |
Why?
|
| Cell-Derived Microparticles | 1 | 2014 | 160 | 0.100 |
Why?
|
| Sex Distribution | 4 | 2015 | 2263 | 0.100 |
Why?
|
| Life Style | 3 | 2020 | 3928 | 0.100 |
Why?
|
| Heart Injuries | 1 | 2014 | 206 | 0.100 |
Why?
|
| Chemokine CXCL12 | 1 | 2014 | 455 | 0.100 |
Why?
|
| Electric Impedance | 1 | 2017 | 794 | 0.100 |
Why?
|
| Vasoconstriction | 1 | 2015 | 594 | 0.100 |
Why?
|
| Executive Function | 1 | 2021 | 1391 | 0.100 |
Why?
|
| Elasticity | 2 | 2011 | 652 | 0.100 |
Why?
|
| Software | 3 | 2021 | 4459 | 0.100 |
Why?
|
| Pyridazines | 1 | 2013 | 200 | 0.100 |
Why?
|
| Platelet Aggregation | 1 | 2015 | 769 | 0.100 |
Why?
|
| Periodicals as Topic | 1 | 2023 | 1462 | 0.100 |
Why?
|
| Primary Prevention | 1 | 2019 | 1187 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2023 | 1480 | 0.090 |
Why?
|
| Reference Values | 3 | 2013 | 4909 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2024 | 5336 | 0.090 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2013 | 430 | 0.090 |
Why?
|
| Estrogens | 2 | 2016 | 1529 | 0.090 |
Why?
|
| Antibodies, Bacterial | 1 | 2017 | 1473 | 0.090 |
Why?
|
| Treatment Outcome | 12 | 2022 | 65180 | 0.090 |
Why?
|
| Colony-Forming Units Assay | 1 | 2011 | 351 | 0.090 |
Why?
|
| Lumbosacral Region | 1 | 2013 | 295 | 0.090 |
Why?
|
| Age Distribution | 2 | 2009 | 2859 | 0.090 |
Why?
|
| Hospital Mortality | 2 | 2022 | 5343 | 0.090 |
Why?
|
| Knee | 1 | 2013 | 271 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2021 | 1940 | 0.090 |
Why?
|
| Joints | 1 | 2013 | 321 | 0.090 |
Why?
|
| Homosexuality | 2 | 2009 | 268 | 0.090 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 170 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2021 | 36537 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2005 | 4057 | 0.090 |
Why?
|
| Thoracic Neoplasms | 1 | 2013 | 267 | 0.090 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 929 | 0.090 |
Why?
|
| Aortic Valve | 2 | 2018 | 1968 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2016 | 645 | 0.090 |
Why?
|
| Heart Defects, Congenital | 2 | 2018 | 4698 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2021 | 1805 | 0.090 |
Why?
|
| Mice | 11 | 2021 | 81792 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2019 | 1526 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 1945 | 0.090 |
Why?
|
| Anthracyclines | 1 | 2012 | 284 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 1892 | 0.090 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 1175 | 0.090 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 13639 | 0.080 |
Why?
|
| Data Collection | 2 | 2010 | 3318 | 0.080 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2014 | 729 | 0.080 |
Why?
|
| Sarcomeres | 1 | 2012 | 379 | 0.080 |
Why?
|
| Cholecalciferol | 1 | 2014 | 550 | 0.080 |
Why?
|
| Pedigree | 1 | 2017 | 4524 | 0.080 |
Why?
|
| Nucleotides | 1 | 2012 | 451 | 0.080 |
Why?
|
| Mortality | 2 | 2018 | 2904 | 0.080 |
Why?
|
| Fontan Procedure | 1 | 2016 | 805 | 0.080 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 2660 | 0.080 |
Why?
|
| Finland | 2 | 2021 | 608 | 0.080 |
Why?
|
| ROC Curve | 2 | 2021 | 3618 | 0.080 |
Why?
|
| Ultrasonography, Doppler | 1 | 2011 | 460 | 0.080 |
Why?
|
| Anal Canal | 2 | 2009 | 376 | 0.080 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2012 | 280 | 0.080 |
Why?
|
| Child | 5 | 2020 | 80499 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3251 | 0.080 |
Why?
|
| Liver Neoplasms | 2 | 2019 | 4352 | 0.080 |
Why?
|
| Glutamine | 1 | 2012 | 575 | 0.080 |
Why?
|
| Ventricular Dysfunction | 1 | 2009 | 143 | 0.080 |
Why?
|
| Stress, Physiological | 2 | 2013 | 1404 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 548 | 0.080 |
Why?
|
| Graft Rejection | 1 | 2022 | 4498 | 0.080 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2013 | 689 | 0.080 |
Why?
|
| Cholesterol, LDL | 3 | 2022 | 2393 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2016 | 1030 | 0.080 |
Why?
|
| Interleukins | 1 | 2013 | 791 | 0.080 |
Why?
|
| Body Weight | 2 | 2016 | 4624 | 0.080 |
Why?
|
| Hospitals | 1 | 2022 | 3889 | 0.080 |
Why?
|
| Adolescent | 5 | 2020 | 88781 | 0.080 |
Why?
|
| Electromyography | 1 | 2013 | 1399 | 0.080 |
Why?
|
| Partial Thromboplastin Time | 1 | 2009 | 202 | 0.070 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2018 | 1211 | 0.070 |
Why?
|
| Diet | 3 | 2022 | 8085 | 0.070 |
Why?
|
| Survival Rate | 5 | 2020 | 12787 | 0.070 |
Why?
|
| Caregivers | 1 | 2020 | 2307 | 0.070 |
Why?
|
| Pregnancy | 3 | 2024 | 30248 | 0.070 |
Why?
|
| Iron | 1 | 2016 | 1814 | 0.070 |
Why?
|
| Immunoassay | 1 | 2011 | 742 | 0.070 |
Why?
|
| Iohexol | 1 | 2008 | 204 | 0.070 |
Why?
|
| Menopause | 1 | 2016 | 1661 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2021 | 3461 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 1530 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2020 | 42468 | 0.070 |
Why?
|
| Imidazoles | 1 | 2013 | 1163 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 2918 | 0.070 |
Why?
|
| Skull Fractures | 1 | 2009 | 202 | 0.070 |
Why?
|
| Communication | 1 | 2021 | 3914 | 0.070 |
Why?
|
| Metagenome | 2 | 2022 | 464 | 0.070 |
Why?
|
| T-Lymphocytes | 2 | 2022 | 10262 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2017 | 2589 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2013 | 2423 | 0.070 |
Why?
|
| Coronary Stenosis | 2 | 2019 | 800 | 0.070 |
Why?
|
| Angiography | 1 | 2012 | 1581 | 0.070 |
Why?
|
| Psychometrics | 3 | 2022 | 3060 | 0.070 |
Why?
|
| Antioxidants | 1 | 2015 | 1670 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 10385 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3230 | 0.070 |
Why?
|
| Ischemia | 3 | 2020 | 1910 | 0.070 |
Why?
|
| Muscle, Skeletal | 2 | 2013 | 4961 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2012 | 844 | 0.070 |
Why?
|
| Hypopituitarism | 1 | 2009 | 253 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2021 | 3969 | 0.070 |
Why?
|
| Papillomavirus Infections | 2 | 2009 | 1638 | 0.070 |
Why?
|
| Cytological Techniques | 1 | 2008 | 218 | 0.070 |
Why?
|
| Cognition | 2 | 2021 | 7048 | 0.070 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2021 | 325 | 0.070 |
Why?
|
| Lipoproteins, LDL | 2 | 2020 | 643 | 0.070 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 1103 | 0.070 |
Why?
|
| Family | 1 | 2017 | 3207 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 4038 | 0.070 |
Why?
|
| Preoperative Care | 2 | 2013 | 2266 | 0.070 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 1885 | 0.060 |
Why?
|
| Radionuclide Ventriculography | 1 | 2005 | 39 | 0.060 |
Why?
|
| Ventricular Function, Right | 3 | 2016 | 629 | 0.060 |
Why?
|
| Range of Motion, Articular | 1 | 2013 | 1595 | 0.060 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 624 | 0.060 |
Why?
|
| Morbidity | 3 | 2017 | 1749 | 0.060 |
Why?
|
| Diet Surveys | 2 | 2021 | 1159 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2013 | 14637 | 0.060 |
Why?
|
| Mediastinal Neoplasms | 1 | 2009 | 403 | 0.060 |
Why?
|
| Amino Acids | 1 | 2012 | 1709 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2021 | 3458 | 0.060 |
Why?
|
| Radiation Injuries | 1 | 2013 | 1181 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 9368 | 0.060 |
Why?
|
| Drug Discovery | 1 | 2013 | 1063 | 0.060 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2013 | 1002 | 0.060 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2009 | 888 | 0.060 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 1224 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2021 | 8062 | 0.060 |
Why?
|
| Glucose Intolerance | 1 | 2009 | 580 | 0.060 |
Why?
|
| Gene Expression | 2 | 2015 | 7584 | 0.060 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2011 | 562 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2014 | 1935 | 0.060 |
Why?
|
| Leukocytes | 1 | 2013 | 2027 | 0.060 |
Why?
|
| Endothelial Cells | 3 | 2014 | 3584 | 0.060 |
Why?
|
| Chi-Square Distribution | 3 | 2016 | 3432 | 0.060 |
Why?
|
| Heart Neoplasms | 1 | 2008 | 375 | 0.060 |
Why?
|
| Up-Regulation | 3 | 2019 | 4136 | 0.060 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 7875 | 0.060 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2022 | 1039 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2013 | 5879 | 0.060 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2005 | 113 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3794 | 0.060 |
Why?
|
| Insulin | 3 | 2013 | 6601 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2015 | 10069 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2008 | 703 | 0.050 |
Why?
|
| Exercise Test | 2 | 2011 | 2180 | 0.050 |
Why?
|
| Knowledge Bases | 1 | 2024 | 96 | 0.050 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2006 | 516 | 0.050 |
Why?
|
| Risk | 2 | 2013 | 9592 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2013 | 2061 | 0.050 |
Why?
|
| Betula | 1 | 2023 | 7 | 0.050 |
Why?
|
| Femoral Artery | 2 | 2019 | 811 | 0.050 |
Why?
|
| Organ Size | 2 | 2020 | 2261 | 0.050 |
Why?
|
| Blood Coagulation | 1 | 2009 | 1166 | 0.050 |
Why?
|
| Contrast Media | 2 | 2022 | 5326 | 0.050 |
Why?
|
| Papillomaviridae | 1 | 2009 | 1137 | 0.050 |
Why?
|
| Morganella | 1 | 2022 | 1 | 0.050 |
Why?
|
| Aminoglycosides | 1 | 2003 | 161 | 0.050 |
Why?
|
| Resistin | 1 | 2022 | 174 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 4423 | 0.050 |
Why?
|
| Growth Differentiation Factors | 1 | 2022 | 99 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2008 | 1036 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 4041 | 0.050 |
Why?
|
| Coronary Angiography | 3 | 2022 | 4494 | 0.050 |
Why?
|
| Lactase | 1 | 2022 | 72 | 0.050 |
Why?
|
| Positron-Emission Tomography | 3 | 2023 | 6546 | 0.050 |
Why?
|
| Bifidobacterium | 1 | 2022 | 99 | 0.050 |
Why?
|
| Mediator Complex | 1 | 2022 | 106 | 0.050 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2012 | 1566 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2013 | 3044 | 0.050 |
Why?
|
| Bacteria | 2 | 2023 | 2209 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2005 | 1027 | 0.050 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2021 | 99 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3247 | 0.050 |
Why?
|
| Cytarabine | 1 | 2003 | 697 | 0.050 |
Why?
|
| Thrombosis | 1 | 2015 | 2949 | 0.050 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 136 | 0.040 |
Why?
|
| Convalescence | 1 | 2021 | 107 | 0.040 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2007 | 1727 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 2495 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 3504 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 1145 | 0.040 |
Why?
|
| Enterococcus faecalis | 1 | 2022 | 244 | 0.040 |
Why?
|
| Ventilators, Mechanical | 1 | 2022 | 291 | 0.040 |
Why?
|
| Meningococcal Vaccines | 1 | 2021 | 96 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 3406 | 0.040 |
Why?
|
| Inflammation | 3 | 2020 | 10846 | 0.040 |
Why?
|
| Genome, Human | 1 | 2013 | 4446 | 0.040 |
Why?
|
| Translations | 1 | 2020 | 84 | 0.040 |
Why?
|
| Goals | 1 | 2005 | 719 | 0.040 |
Why?
|
| Apolipoprotein B-100 | 1 | 2020 | 157 | 0.040 |
Why?
|
| Diagnosis, Differential | 4 | 2020 | 12949 | 0.040 |
Why?
|
| Leukemia, Myeloid | 1 | 2003 | 696 | 0.040 |
Why?
|
| Europe | 2 | 2021 | 3423 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2020 | 2229 | 0.040 |
Why?
|
| Lipoproteins, VLDL | 1 | 2020 | 198 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2020 | 355 | 0.040 |
Why?
|
| Peptides | 2 | 2022 | 4331 | 0.040 |
Why?
|
| Authorship | 1 | 2023 | 288 | 0.040 |
Why?
|
| Pyridines | 1 | 2011 | 2889 | 0.040 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2021 | 216 | 0.040 |
Why?
|
| Peroxidase | 1 | 2022 | 605 | 0.040 |
Why?
|
| Immunity, Innate | 2 | 2022 | 3078 | 0.040 |
Why?
|
| ABO Blood-Group System | 1 | 2022 | 380 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2010 | 3140 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10428 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2023 | 1589 | 0.040 |
Why?
|
| Videoconferencing | 1 | 2021 | 209 | 0.040 |
Why?
|
| Apolipoprotein A-I | 1 | 2020 | 304 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2005 | 2910 | 0.040 |
Why?
|
| Live Birth | 1 | 2023 | 518 | 0.040 |
Why?
|
| Psychology | 1 | 2021 | 354 | 0.040 |
Why?
|
| Leucine | 1 | 2020 | 546 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2010 | 2891 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2021 | 1060 | 0.040 |
Why?
|
| Apoptosis | 1 | 2015 | 9511 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 1043 | 0.040 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2021 | 422 | 0.040 |
Why?
|
| Immunization Programs | 1 | 2021 | 267 | 0.040 |
Why?
|
| Pharmacists | 1 | 2021 | 261 | 0.040 |
Why?
|
| Hirudins | 1 | 2019 | 179 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 11080 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2007 | 2185 | 0.040 |
Why?
|
| Glucose | 2 | 2022 | 4334 | 0.040 |
Why?
|
| Apolipoproteins | 1 | 2020 | 327 | 0.040 |
Why?
|
| Professional Role | 1 | 2021 | 314 | 0.040 |
Why?
|
| Metagenomics | 1 | 2022 | 473 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 7424 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2021 | 994 | 0.040 |
Why?
|
| Radial Artery | 1 | 2019 | 189 | 0.040 |
Why?
|
| Telephone | 1 | 2021 | 627 | 0.040 |
Why?
|
| Cachexia | 1 | 2019 | 200 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18289 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2019 | 614 | 0.040 |
Why?
|
| Radiometry | 1 | 2023 | 804 | 0.040 |
Why?
|
| Dietary Fiber | 1 | 2022 | 767 | 0.040 |
Why?
|
| HIV Seronegativity | 2 | 2009 | 209 | 0.040 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2017 | 103 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2020 | 999 | 0.040 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2017 | 318 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2023 | 12769 | 0.040 |
Why?
|
| Demography | 1 | 2022 | 1641 | 0.030 |
Why?
|
| Torsion, Mechanical | 1 | 2017 | 15 | 0.030 |
Why?
|
| Monitoring, Ambulatory | 1 | 2020 | 357 | 0.030 |
Why?
|
| Biometry | 1 | 2020 | 571 | 0.030 |
Why?
|
| Supine Position | 1 | 2017 | 209 | 0.030 |
Why?
|
| Pneumococcal Vaccines | 1 | 2021 | 413 | 0.030 |
Why?
|
| Intermittent Claudication | 1 | 2019 | 300 | 0.030 |
Why?
|
| Antithrombins | 1 | 2019 | 295 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2019 | 523 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2020 | 1132 | 0.030 |
Why?
|
| Horses | 1 | 2017 | 293 | 0.030 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2019 | 580 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2005 | 1263 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2021 | 722 | 0.030 |
Why?
|
| Vero Cells | 1 | 2017 | 481 | 0.030 |
Why?
|
| Half-Life | 1 | 2017 | 645 | 0.030 |
Why?
|
| Healthcare Disparities | 2 | 2023 | 3412 | 0.030 |
Why?
|
| Xanthines | 1 | 2016 | 121 | 0.030 |
Why?
|
| Ribonucleosides | 1 | 2016 | 79 | 0.030 |
Why?
|
| Acute Disease | 3 | 2017 | 7232 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2020 | 674 | 0.030 |
Why?
|
| Pulse | 1 | 2016 | 214 | 0.030 |
Why?
|
| Immune System | 1 | 2021 | 799 | 0.030 |
Why?
|
| Receptor, erbB-2 | 2 | 2020 | 2592 | 0.030 |
Why?
|
| Kidney | 1 | 2011 | 7066 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2005 | 2019 | 0.030 |
Why?
|
| Japan | 1 | 2020 | 1415 | 0.030 |
Why?
|
| Lipoprotein(a) | 1 | 2020 | 488 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 1827 | 0.030 |
Why?
|
| Oncogenes | 1 | 2021 | 1232 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2008 | 2328 | 0.030 |
Why?
|
| Models, Cardiovascular | 2 | 2012 | 979 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 2017 | 735 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1002 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2021 | 1187 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2016 | 368 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 500 | 0.030 |
Why?
|
| Models, Biological | 2 | 2008 | 9441 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 2019 | 956 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2020 | 1152 | 0.030 |
Why?
|
| Angina, Unstable | 1 | 2019 | 893 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2020 | 1185 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2017 | 479 | 0.030 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2015 | 139 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2022 | 937 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 939 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2017 | 328 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2020 | 1020 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2022 | 1303 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2005 | 2918 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 1188 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2022 | 4015 | 0.030 |
Why?
|
| Sweden | 1 | 2017 | 1381 | 0.030 |
Why?
|
| Compliance | 1 | 2014 | 100 | 0.030 |
Why?
|
| Residence Characteristics | 2 | 2015 | 2115 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2020 | 6832 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2021 | 1375 | 0.030 |
Why?
|
| Warfarin | 1 | 2022 | 1494 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 2666 | 0.030 |
Why?
|
| Renin | 1 | 2016 | 647 | 0.030 |
Why?
|
| Triage | 1 | 2021 | 996 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 2335 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2020 | 2075 | 0.030 |
Why?
|
| Cholesterol Esters | 1 | 2013 | 68 | 0.030 |
Why?
|
| Patient Admission | 1 | 2021 | 1364 | 0.030 |
Why?
|
| Antimalarials | 1 | 2020 | 911 | 0.030 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 778 | 0.030 |
Why?
|
| Brain | 2 | 2021 | 27178 | 0.030 |
Why?
|
| Rectus Abdominis | 1 | 2013 | 101 | 0.030 |
Why?
|
| Pectoralis Muscles | 1 | 2013 | 86 | 0.030 |
Why?
|
| HIV Seropositivity | 2 | 2009 | 961 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2021 | 2865 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2570 | 0.030 |
Why?
|
| Galectins | 1 | 2016 | 294 | 0.030 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 2012 | 43 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 1996 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2013 | 127 | 0.030 |
Why?
|
| Transaminases | 1 | 2013 | 199 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 1425 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 286 | 0.020 |
Why?
|
| Independent Living | 1 | 2016 | 585 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 4850 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2022 | 2081 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 1663 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2023 | 4772 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2021 | 2445 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2003 | 2097 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 322 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2011 | 1426 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2020 | 2240 | 0.020 |
Why?
|
| Computational Biology | 1 | 2024 | 3558 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 2779 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2013 | 412 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2016 | 706 | 0.020 |
Why?
|
| Aldosterone | 1 | 2016 | 881 | 0.020 |
Why?
|
| Amino Acids, Aromatic | 1 | 2011 | 36 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 2415 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2021 | 2242 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 2010 | 0.020 |
Why?
|
| Thorax | 1 | 2013 | 553 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 640 | 0.020 |
Why?
|
| Testosterone | 2 | 2011 | 2495 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2016 | 1188 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3805 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2010 | 66 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6307 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2014 | 1639 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2011 | 610 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 6492 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2022 | 3683 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2018 | 1392 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2720 | 0.020 |
Why?
|
| Fasting | 1 | 2016 | 1606 | 0.020 |
Why?
|
| Calcium | 1 | 2022 | 5765 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2012 | 15749 | 0.020 |
Why?
|
| Iron Overload | 1 | 2012 | 244 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2020 | 2965 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 2709 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 1105 | 0.020 |
Why?
|
| Niacinamide | 1 | 2011 | 419 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2016 | 3623 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 582 | 0.020 |
Why?
|
| Injections, Jet | 1 | 2008 | 8 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2013 | 1602 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 1739 | 0.020 |
Why?
|
| Anus Diseases | 1 | 2009 | 53 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 2011 | 559 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4405 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2015 | 1470 | 0.020 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2011 | 558 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2021 | 2521 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2013 | 1964 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4207 | 0.020 |
Why?
|
| Models, Animal | 1 | 2015 | 2120 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2011 | 402 | 0.020 |
Why?
|
| San Francisco | 1 | 2008 | 165 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2019 | 4249 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2011 | 536 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 10730 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2013 | 1865 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2018 | 2685 | 0.020 |
Why?
|
| Cell Line | 2 | 2013 | 15542 | 0.020 |
Why?
|
| Health Behavior | 1 | 2019 | 2649 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 4642 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 2771 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 1792 | 0.020 |
Why?
|
| Premenopause | 1 | 2011 | 1038 | 0.020 |
Why?
|
| Registries | 1 | 2023 | 8293 | 0.020 |
Why?
|
| Public Health | 1 | 2020 | 2678 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2009 | 682 | 0.020 |
Why?
|
| Biopsy | 2 | 2009 | 6754 | 0.020 |
Why?
|
| Gadolinium | 1 | 2012 | 965 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 1885 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3751 | 0.020 |
Why?
|
| Cytokines | 1 | 2021 | 7424 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 1377 | 0.020 |
Why?
|
| Sarcoidosis | 1 | 2012 | 532 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 898 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 9245 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2018 | 2084 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2022 | 4752 | 0.020 |
Why?
|
| Canada | 1 | 2011 | 2119 | 0.020 |
Why?
|
| Boston | 1 | 2018 | 9337 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11201 | 0.020 |
Why?
|
| Vena Cava, Inferior | 1 | 2008 | 463 | 0.010 |
Why?
|
| Cytodiagnosis | 1 | 2009 | 450 | 0.010 |
Why?
|
| Edema | 1 | 2009 | 760 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2013 | 2486 | 0.010 |
Why?
|
| Causality | 1 | 2011 | 1246 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2013 | 1944 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2019 | 3854 | 0.010 |
Why?
|
| Medicare | 1 | 2022 | 6821 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4255 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 2137 | 0.010 |
Why?
|
| Depressive Disorder, Major | 1 | 2022 | 4809 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2740 | 0.010 |
Why?
|
| Androgens | 1 | 2011 | 1278 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6499 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2014 | 4020 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2013 | 5381 | 0.010 |
Why?
|
| Shock, Cardiogenic | 1 | 2009 | 704 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 13024 | 0.010 |
Why?
|
| Self Report | 1 | 2014 | 3772 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 5442 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 2794 | 0.010 |
Why?
|
| Connecticut | 1 | 2003 | 365 | 0.010 |
Why?
|
| Homeostasis | 1 | 2013 | 3336 | 0.010 |
Why?
|
| Postmenopause | 1 | 2011 | 2516 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 3109 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 5787 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 6952 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 2009 | 974 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2010 | 1883 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2011 | 6319 | 0.010 |
Why?
|
| Fatigue | 1 | 2009 | 1550 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 2003 | 641 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2016 | 3286 | 0.010 |
Why?
|
| Defibrillators, Implantable | 1 | 2011 | 1490 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7477 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2012 | 2859 | 0.010 |
Why?
|
| Dyspnea | 1 | 2009 | 1352 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12433 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2013 | 4912 | 0.010 |
Why?
|
| Neutropenia | 1 | 2005 | 893 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6061 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 1327 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 2473 | 0.010 |
Why?
|
| Creatinine | 1 | 2003 | 1915 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2005 | 1171 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 8038 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2349 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2003 | 1272 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 9594 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 11888 | 0.010 |
Why?
|
| Anemia | 1 | 2005 | 1510 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 6203 | 0.010 |
Why?
|
| Recurrence | 1 | 2003 | 8498 | 0.010 |
Why?
|